story of the week
Scientists Tie Third Clinical Trial Death to Lecanemab, an Experimental Drug for Alzheimer’s Disease
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Science (New York, N.Y.)